FDA Adverse Event Injury Summary report: N

ANIMAS INSULIN INFUSION PUMP

MDR report key: 3233515 · Received July 18, 2013

Report

Report Number
2531779-2013-11235
Event Type
Injury
Date Received
July 18, 2013
Report Date
June 20, 2013
Manufacturer
ANIMAS CORPORATION
Product Code
LZG
PMA / PMN Number
K042873
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THE PUMP HAS BEEN RETURNED AND EVALUATED BY PRODUCT ANALYSIS ON 09/11/2013 WITH THE FOLLOWING FINDINGS: EVALUATION REVEALED THAT THE PUMP WAS EXERCISED FOR A 24-HR DURATION PERIOD WITH A 1.0U/HR BASAL RATE; AND NO CHANGES IN THE BASAL RATE OCCURRED DURING THIS TIME PERIOD. THE PUMP WAS FOUND TO BE DELIVERING WITHIN THE REQUIRED SPECIFICATION AT THE CONCLUSION OF THE 29HR FLOW ACCURACY TEST. INVESTIGATORS WERE UNABLE TO DUPLICATE THE REPORTED COMPLAINT. THERE WAS NO DEFECT FOUND.

Additional Manufacturer Narrative · 1

THE PUMP HAS NOT BEEN RETURNED TO ANIMAS FOR EVALUATION. ANIMAS HAS CONDUCTED A REVIEW OF THE DEVICE HISTORY RECORD FOR THIS PUMP AND CONFIRMED THAT IT WAS OPERATING WITHIN REQUIRED SPECIFICATIONS AT THE TIME OF RELEASE. IF THE DEVICE IS RETURNED, AN EVALUATION SHALL BE COMPLETED AND A SUPPLEMENTAL REPORT WILL BE FILED. NO CONCLUSIONS CAN BE MADE AT THIS TIME.

Description of Event or Problem · 1

ON (B)(6) 2013, THE LAY-USER/PATIENT CONTACTED ANIMAS TO REPORT HE WAS IN THE HOSPITAL FOR 2 WEEKS, BEING TREATED FOR A BLOOD GLUCOSE READING GREATER 800 MG/DL. THE PATIENT REPORTEDLY HAD SYMPTOMS OF VOMITING AND DEHYDRATION ON (B)(6) 2013. DURING HIS HOSPITAL STAY, THE PATIENT TAKEN OFF OF INSULIN PUMP THERAPY AND WAS TREATED WITH IV INSULIN. UPON HIS RELEASE FROM THE HOSPITAL, THE PATIENT RESUMED INSULIN PUMP THERAPY. WHILE HE WAS ON INSULIN PUMP THERAPY, IT WAS NOTED THE PATIENT DID NOT GET ANY INSULIN ON (B)(6) 2013 FROM 12 AM TO 2 AM. THE PATIENT DENIED MAKING ANY CHANGES TO THE SUBJECT PUMP PRIOR TO THE ISSUE. DURING TROUBLESHOOTING, THE PATIENT VERIFIED THERE WAS A DISCREPANCY IN THE BASAL SEGMENT ON (B)(6) 2013. THE BASAL SEGMENT WAS NOT PROGRAMMED AS INTENDED FROM 12:30 AM TO 2:30 AM. THE PRODUCT WAS REQUESTED BACK FOR INVESTIGATION. THIS COMPLAINT IS BEING REPORTED DUE TO THE UNRESOLVED BASAL SEGMENT DISCREPANCY ISSUE. IN ADDITION, THE PATIENT HAD UNEXPLAINED HYPERGLYCEMIA ABOVE 800 MG/DL AND REQUIRED HOSPITALIZATION WHILE ON INSULIN PUMP THERAPY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
334064 ANIMAS INSULIN INFUSION PUMP INSULIN INFUSION PUMP LZG ANIMAS CORPORATION

Patients

Seq Age Sex Outcome Treatment
1 63 YR Hospitalization| L| R